Trigon Agri will publish its interim report for the third quarter 2015 on Monday, November 30, 2015 at 8:00 CET. Analysts, investors and media are invited to attend a telephone conference that will be held at 10:00 CET on the same day. Program: Joakim Helenius, Chairman of the Board, and Ülo Adamson, President and CEO, will present and comment upon the results. There will also be an opportunity to ask questions. To participate in the telephone conference, please call one of the following numbers: SE: +46 8 505 564 74 UK: +44 203 364 5374 US: +1 855 753 2230 FI: +358 981710460 NO: +47 235 002 10 DK: +45 354 45 580 CH: +41 225 675 541 The presentation material will be available on www.trigonagri.com before the telephone conference starts. A recording of the telephone conference will be available afterwards on www.trigonagri.com. Investor enquiries: Mr. Ülo Adamson, President and CEO of Trigon Agri A/S, Tel: +372 66 79200, E -mail: mail@trigonagri.com About Trigon Agri Trigon Agri is a leading integrated soft commodities production, storage and trading company with operations in Ukraine, Russia and Estonia. Trigon Agri’s shares are traded on the main market of NASDAQ OMX Stockholm. Trigon Agri is managed under a management agreement by Trigon Capital, a leading Central and Eastern European operational management firm with around USD 1 billion of assets under management. For subscription to Company Announcements please contact us: mail@trigonagri.com. If you do not want to receive Trigon Agri press releases automatically in the future please send an e-mail to the following address: unsubscribe@trigonagri.com (mail@trigonagri.com).
Trigon Agri A/S: Invitation to 3Q 2015 results presentation
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Eli Lilly's Pirtobrutinib Shows Promising Results in CLL Trials
Pirtobrutinib's Efficacy in Chronic Lymphocytic Leukemia Studies Eli Lilly and Company (NYSE: LLY) made notable advancements in chronic lymphocytic leukemia (CLL) research with their drug, pirtobrutinib. The recent study, known as BRUIN CLL-321, demonstrated that pirtobrutinib significantly reduced the risk of disease progression or death by 46% compared to previous...
Continue Reading
Exploring Axon Enterprise's Options Trading Dynamics
Investors' Insights on Axon Enterprise In the ever-evolving world of stock market investments, insights from institutional and wealthy individual investors can carry significant weight. Recently, there has been a noticeable bullish stance on Axon Enterprise (NASDAQ: AXON), raising curiosity among retail traders about potential future movements. Unusual Options Activity...
Continue Reading
Aventis Energy Releases Technical Report on Corvo Project
Aventis Energy Files NI 43-101 Technical Report on Corvo Project Aventis Energy Inc. (“Aventis” or the “Company”) (CNSX: AVE | Frankfurt: C0O0 | Other OTC: VBAMF) is excited to announce that its partner, Standard Uranium Ltd., has filed a technical report detailing findings and exploration data from the Corvo Project. This report, titled "Technical Report on the...
Continue Reading
Drucker + Falk Celebrates Community Commitment Through Cleanup Events
Drucker + Falk's Dedication to Community Engagement Drucker + Falk, a prominent name in multifamily property management, has made remarkable strides in community involvement through its annual clean-up initiatives. This year, they marked the third consecutive clean-up campaign aimed at enhancing local environments, aligning their efforts with the mission of Keep America...
Continue Reading
Exploring the Future of Mental Health: The Wholeness Center
Revolutionizing Mental Health with Integrative Approaches The Wholeness Center has gained state approval to offer legal psilocybin-assisted therapy, marking a significant milestone as the sole licensed healing center in Northern Colorado. This innovative facility combines the realms of psychedelic therapy with integrative psychiatry, aiming to provide comprehensive mental...
Continue Reading